Autopsy report · NCT01056757

Treatment With Ribavirin for Patients With Metastatic Breast Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Study closed because of new overlapping study with ribavirin.”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month after it had already started.
Ran for about 11 months before it stopped.
4 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: Jewish General Hospital
Sponsor type: University, hospital or other
Conditions: Metastatic Breast Cancer
Interventions: Ribavirin
Participants: 4
Sites: 1
Countries: Canada

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.